The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults
1 other identifier
observational
5,500
1 country
2
Brief Summary
This is a multicenter cross-sectional study on the prevalence of Irritable Bowel Syndrome and the risk factors associated with it. The Rome IV criteria is used for diagnosing IBS. A questionnaire-guided interview will be applied to all subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2022
CompletedFirst Posted
Study publicly available on registry
April 22, 2022
CompletedStudy Start
First participant enrolled
April 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2022
CompletedJune 14, 2022
June 1, 2022
1 month
April 15, 2022
June 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Prevalence of Irritable Bowel Syndrome
Collaborators will make an interview questions using ROME IV to diagnose IBS among adults.
30 days
Secondary Outcomes (5)
Physical activity as risk factor for IBS
30 days
Perceived Stress Scale as risk factor for IBS
30 days
Fatigue as risk factor for IBS
30 days
Diet and weight questions as risk factor for IBS
30 days
Habits as risk factor for IBS
30 days
Study Arms (2)
Patients diagnosed with IBS
Collaborators will use Rome IV criteria for diagnosing IBS, and then divide participants into those with and without the disease.
Patients not diagnosed with IBS
Collaborators will use Rome IV criteria for diagnosing IBS, and then divide participants into those with and without the disease.
Interventions
Collaborators will use Rome IV criteria for diagnosing IBS by the presence of the abdominal pain at least once a week in the last 3 months, in addition to at least two of the following: abdominal pain related to defecation, change in stool frequency, or shape.
Eligibility Criteria
Community sample.
You may qualify if:
- Volunteer to participate in the study
You may not qualify if:
- Poorly-controlled hyperthyroidism
- Poorly-controlled hypothyroidism
- Poorly-controlled hyperparathyroidism
- Liver disease
- Paralysis
- Parasitic diseases (worms ...)
- Celiac disease
- Inflammatory bowel disease (Crohn's disease or Ulcerative colitis)
- Lactose intolerance
- Cancer or tumor in the digestive tract
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ahmad Yamen Arnaout
Aleppo, Syria
University of Aleppo
Aleppo, Syria
Related Publications (7)
Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016 Feb 18:S0016-5085(16)00222-5. doi: 10.1053/j.gastro.2016.02.031. Online ahead of print.
PMID: 27144627BACKGROUNDLongstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006 Apr;130(5):1480-91. doi: 10.1053/j.gastro.2005.11.061.
PMID: 16678561BACKGROUNDDrossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology. 2005 Mar;128(3):580-9. doi: 10.1053/j.gastro.2004.12.006.
PMID: 15765393BACKGROUNDPalsson OS, Baggish JS, Turner MJ, Whitehead WE. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment. Am J Gastroenterol. 2012 Feb;107(2):286-95. doi: 10.1038/ajg.2011.358. Epub 2011 Nov 8.
PMID: 22068664BACKGROUNDZamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019 Jul;50(2):132-143. doi: 10.1111/apt.15325. Epub 2019 Jun 3.
PMID: 31157418BACKGROUNDGralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000 Sep;119(3):654-60. doi: 10.1053/gast.2000.16484.
PMID: 10982758BACKGROUNDArnaout AY, Nerabani Y, Douba Z, Kassem LH, Arnaout K, Shabouk MB, Zayat H, Mayo W, Bezo Y, Arnaout I, Yousef A, Zeina MB, Aljarad Z; PRIBS Study Team. The prevalence and risk factors of irritable bowel syndrome (PRIBS study) among adults in low- and middle-income countries: A multicenter cross-sectional study. Health Sci Rep. 2023 Oct 4;6(10):e1592. doi: 10.1002/hsr2.1592. eCollection 2023 Oct.
PMID: 37808932DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 15, 2022
First Posted
April 22, 2022
Study Start
April 25, 2022
Primary Completion
May 25, 2022
Study Completion
June 10, 2022
Last Updated
June 14, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share
Not available to other researchers.